Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice

NCT04454723 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-03-05

No results posted yet for this study

Summary

The purpose of this pilot research study is to evaluate the effectiveness of blood and platelet transfusions in improving symptoms and quality of life of patients enrolled in hospice.

Conditions

  • Hematologic Malignancy

Interventions

PROCEDURE

Blood and/or platelet transfusion

The transfused patients will receive one unit each of blood and/or platelet transfusions once a week based on CTCAE symptom grade 2 or greater of anemia and/or thrombocytopenia.

PROCEDURE

Complete blood count (CBC) collection

CBC will be collected from patients weekly while on this protocol.

Sponsors & Collaborators

  • University of Oklahoma

    lead OTHER

Principal Investigators

  • Jennifer Holter, MD · University of Oklahoma

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-14
Primary Completion
2023-08-16
Completion
2023-08-17

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04454723 on ClinicalTrials.gov